Free Trial

Progyny, Inc. (NASDAQ:PGNY) Director Cheryl Scott Sells 2,675 Shares

Progyny logo with Medical background

Progyny, Inc. (NASDAQ:PGNY - Get Free Report) Director Cheryl Scott sold 2,675 shares of Progyny stock in a transaction dated Wednesday, June 11th. The shares were sold at an average price of $22.07, for a total transaction of $59,037.25. Following the completion of the transaction, the director now directly owns 14,112 shares of the company's stock, valued at $311,451.84. This trade represents a 15.93% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link.

Progyny Stock Performance

Shares of NASDAQ:PGNY traded down $0.52 during trading on Friday, reaching $21.03. The company had a trading volume of 819,289 shares, compared to its average volume of 1,711,295. The firm's fifty day moving average is $21.96 and its 200 day moving average is $20.61. Progyny, Inc. has a twelve month low of $13.39 and a twelve month high of $30.42. The firm has a market capitalization of $1.80 billion, a PE ratio of 36.26, a price-to-earnings-growth ratio of 2.39 and a beta of 1.32.

Progyny (NASDAQ:PGNY - Get Free Report) last released its earnings results on Thursday, May 8th. The company reported $0.17 EPS for the quarter, missing analysts' consensus estimates of $0.45 by ($0.28). Progyny had a return on equity of 11.36% and a net margin of 5.03%. The business had revenue of $324.04 million during the quarter, compared to the consensus estimate of $307.86 million. During the same quarter in the previous year, the firm earned $0.17 earnings per share. The firm's revenue for the quarter was up 16.5% compared to the same quarter last year. Equities analysts predict that Progyny, Inc. will post 0.6 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Progyny

Hedge funds have recently made changes to their positions in the company. New York State Teachers Retirement System boosted its stake in Progyny by 0.7% in the 1st quarter. New York State Teachers Retirement System now owns 73,200 shares of the company's stock worth $1,635,000 after purchasing an additional 500 shares during the period. Voya Investment Management LLC boosted its stake in Progyny by 1.4% in the 4th quarter. Voya Investment Management LLC now owns 51,792 shares of the company's stock worth $893,000 after purchasing an additional 701 shares during the period. Polen Capital Management LLC boosted its stake in Progyny by 0.3% in the 1st quarter. Polen Capital Management LLC now owns 261,506 shares of the company's stock worth $5,842,000 after purchasing an additional 798 shares during the period. Militia Capital Partners LP boosted its stake in Progyny by 100.0% in the 1st quarter. Militia Capital Partners LP now owns 2,000 shares of the company's stock worth $45,000 after purchasing an additional 1,000 shares during the period. Finally, Invesco Ltd. boosted its stake in Progyny by 0.4% in the 1st quarter. Invesco Ltd. now owns 275,936 shares of the company's stock worth $6,164,000 after purchasing an additional 1,117 shares during the period. Hedge funds and other institutional investors own 94.93% of the company's stock.

Analyst Ratings Changes

PGNY has been the subject of a number of analyst reports. Canaccord Genuity Group reduced their target price on shares of Progyny from $23.00 to $21.00 and set a "hold" rating for the company in a research note on Monday, May 12th. BTIG Research raised shares of Progyny from a "neutral" rating to a "buy" rating and set a $28.00 target price for the company in a research note on Monday, March 31st. Seven research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $23.45.

Read Our Latest Stock Report on PGNY

Progyny Company Profile

(Get Free Report)

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.

Further Reading

Should You Invest $1,000 in Progyny Right Now?

Before you consider Progyny, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Progyny wasn't on the list.

While Progyny currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Cheap Growth Stocks Set to Explode This Summer
The Next NVIDIA? Quantum Computing Stocks Set for Explosive Growth
5 Stocks to BUY NOW in July 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines